SpringerLink
Log in

Anticoagulants/aspirin

Lack of efficacy

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Rubalcava-Lara L, et al. Treatment of APS Patients with Rivaroxaban or Apixaban: A Cohort Single-Center Study. Research and Practice in Thrombosis and Haemostasis 7 (Suppl. 2): 944-945 abstr. PB0430, Oct 2023. Available from: URL: https://dx.doi.org/10.1016/j.rpth.2023.101712 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anticoagulants/aspirin. Reactions Weekly 2001, 33 (2024). https://doi.org/10.1007/s40278-024-55073-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-55073-4

Search

Navigation